RT Journal Article
SR Electronic
T1 A Machine Learning Classification of Individuals with Mild Cognitive Impairment into Variants from Writing
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.02.16.24302965
DO 10.1101/2024.02.16.24302965
A1 Kim, Hana
A1 Hillis, Argye
A1 Themistocleous, Charalambos
YR 2024
UL http://medrxiv.org/content/early/2024/04/22/2024.02.16.24302965.abstract
AB Introduction Individuals with Mild Cognitive Impairment (MCI), a transitional stage between cognitively healthy aging and dementia, are characterized by subtle neurocognitive changes. Clinically, they can be grouped into two main variants, namely into patients with amnestic MCI (aMCI) and non-amnestic MCI (naMCI). The distinction of the two variants is known to be clinically significant as they exhibit different progression rates to dementia. However, it has been particularly challenging to classify the two variants robustly. Recent research indicates that linguistic changes may manifest as one of the early indicators of pathology. Therefore, we focused on MCI’s discourse-level writing samples in this study. We hypothesized that a written picture description task can provide information that can be used as an ecological, cost-effective classification system between the two variants.Methods We included one hundred sixty-nine individuals diagnosed with either aMCI or naMCI who received neurophysiological evaluations in addition to a short-written picture description task. Natural Language Processing (NLP) and BERT pre-trained Language Models were utilized to analyze the writing samples.Results We showed that the written picture description task provided 90% overall classification accuracy for the best classification models, which performs better than cognitive measures.Discussion Written discourses analyzed the AI models can automatically assess individuals with aMCI and naMCI and facilitate diagnosis, prognosis, therapy planning, and evaluation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of Johns Hopkins University gave ethical approval for this work (IRB00266221). The data were collected between November 1st, 2020, and May 30th, 2022. They were subsequently accessed on August 1st 2023 for the purposes of this study.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData are available upon requests from the authors.